Eliquis® Blood Thinner Lawsuits

First approved by the U.S. Food and Drug Administration in 2012, Eliquis® (apixaban) is a prescription blood-thinning drug designed to reduce the risk of blood clots and stroke. But Eliquis has been linked to serious side effects, and patients who take the drug may face an increased risk of severe bleeding, stroke, or blood clots.

If you or a loved one were injured or hospitalized after taking Eliquis, Ferrer, Poirot & Wansbrough wants to help. Our drug injury lawyers have more than 30 years of experience taking on big pharmaceutical companies, and we’re ready to fight for you. Contact us 24 hours a day, 7 days a week—just dial (800) 210-8503 or complete a free initial consultation form to get started.

Eliquis® Severe Bleeding Dangers

For decades, doctors prescribed warfarin—marketed under the brand name Coumadin®—to reduce the risk of blood clots and stroke. Over the last few years, drug manufacturers sought to capitalize on the market segment with newer—and potentially unsafe—alternatives.

Unlike warfarin, Eliquis and other next-generation blood thinners don’t require regular blood tests, making them a popular treatment among both doctors and patients. But unlike warfarin, Eliquis has no counteracting drug to stop bleeding once it starts. As a result, patients taking Eliquis face an increased risk of major bleeding events.

Eliquis® Side Effect Risks

Patients taking Eliquis may face an increased risk of severe side effects, such as:

  • Blood clots
  • Gastrointestinal bleeding
  • Hemorrhagic stroke (brain bleeding)
  • Intracranial bleeding (bleeding in the skull)
  • Uncontrolled bleeding

Get Help With Your Eliquis® Lawsuit

The law limits the amount of time drug injury victims have to file lawsuits. If you or your loved one were hospitalized while taking Eliquis, or if you lost a family member due to severe Eliquis side effects, you need to take action now. Contact Ferrer, Poirot & Wansbrough, and let our drug injury lawyers help protect your rights to compensation.

Coumadin® and Eliquis® are registered trademarks of Bristol-Myers Squibb Company and are used here only for the purpose of identifying the products in question.

This law firm is not associated with, sponsored by, or affiliated with Bristol-Myers Squibb Company or the U.S. Food and Drug Administration.